High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

Arnaud Jaccard, Philippe Moreau, Véronique Leblond, +16

New England Journal of Medicine

Long-Term Outcome of Arterial Lesions in Behçet Disease

David Saadoun, Bouchra Asli, B. Wechsler, +11

Medicine

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

N. Costedoat‐Chalumeau, Lionel Galicier, O. Aumaître, +110

Annals of the Rheumatic Diseases

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

M. Jallouli, Lionel Galicier, Noël Zahr, +26

Arthritis & Rheumatology

Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases

Stéphanie Harel, M. Mohr, Isabelle Jahn, +8

British Journal of Haematology

Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications

Marion Malphettes, Laurence Gérard, Lionel Galicier, +15

Clinical Infectious Diseases

ImmunodeficienciesAdult-onset Immunodeficiency RemarkableImmunologyPathologyInvasive Infections +14

Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients

L. Gusdorf, Bouchra Asli, S. Barbarot, +17

Allergy

Efficacy of lenalidomide in <scp>POEMS</scp> syndrome: A retrospective study of 20 patients

Bruno Royer, Lavinia Merlusca, Julie Abraham, +21

American Journal of Hematology

Retrospective StudyClinical DisordersPeripheral EdemaPoems SyndromePsychiatry +9

Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up

Y. Schoindre, M. Jallouli, Marie‐Laure Tanguy, +29

Lupus Science & Medicine

Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients

M.R. Vignon, Vincent Javaugue, Mariam P. Alexander, +12

Leukemia

Retrospective SeriesUrologyHematologyCurrent Anti-myeloma TherapiesPathology +2